These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 28905105)

  • 1. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
    Ruys AT; Bennink RJ; van Westreenen HL; Engelbrecht MR; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2011 Apr; 13(4):256-62. PubMed ID: 21418131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
    Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S
    Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
    Park MS; Lee SM
    Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
    Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li X; Zhang Y; Zhang Y
    BMC Geriatr; 2018 Jul; 18(1):150. PubMed ID: 29976141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
    Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
    Kim NH; Lee SR; Kim YH; Kim HJ
    Korean J Radiol; 2020 Dec; 21(12):1355-1366. PubMed ID: 32767862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
    Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ
    J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
    Corvera CU; Blumgart LH; Akhurst T; DeMatteo RP; D'Angelica M; Fong Y; Jarnagin WR
    J Am Coll Surg; 2008 Jan; 206(1):57-65. PubMed ID: 18155569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.
    Kitamura K; Hatano E; Higashi T; Seo S; Nakamoto Y; Narita M; Taura K; Yasuchika K; Nitta T; Yamanaka K; Doi R; Ikai I; Uemoto S
    J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):39-46. PubMed ID: 20503059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of Prognostic Impact of Tumor SUVmax by
    Yoh T; Seo S; Morino K; Fuji H; Ikeno Y; Ishii T; Taura K; Nakamoto Y; Higashi T; Kaido T; Uemoto S
    World J Surg; 2019 May; 43(5):1323-1331. PubMed ID: 30680501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
    Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
    J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
    Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM
    Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
    Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
    Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
    Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
    Petrowsky H; Wildbrett P; Husarik DB; Hany TF; Tam S; Jochum W; Clavien PA
    J Hepatol; 2006 Jul; 45(1):43-50. PubMed ID: 16690156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
    Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.